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http://www.cerebellumandataxias.com/content/1/1/3RESEARCH Open AccessFunctional contributions of glutamate
transporters at the parallel fibre to Purkinje
neuron synapse–relevance for the progression of
cerebellar ataxia
Emmet M Power and Ruth M Empson*Abstract
Background: Rapid uptake of glutamate by neuronal and glial glutamate transporters (EAATs, a family of excitatory
amino acid transporters) is critical for shaping synaptic responses and for preventing excitotoxicity. Two of these
transporters, EAAT4 in Purkinje neurons (PN) and EAAT1 in Bergmann glia are both enriched within the cerebellum
and altered in a variety of human ataxias.
Results: PN excitatory synaptic responses and firing behaviour following high frequency parallel fibre (PF) activity
commonly encountered during sensory stimulation in vivo were adversely influenced by acute inhibition of
glutamate transporters. In the presence of a non-transportable blocker of glutamate transporters we observed very
large amplitude and duration excitatory postsynaptic currents accompanied by excessive firing of the PNs. A com-
bination of AMPA and mGluR1, but not NMDA, type glutamate receptor activation powered the hyper-excitable PN
state. The enhanced PN excitability also recruited a presynaptic mGluR4 dependent mechanism that modified short
term plasticity at the PF synapse.
Conclusions: Our findings indicate that reduced glutamate transporter activity, as occurs in the early stages of
some forms of human cerebellar ataxias, excessively excites PNs and disrupts the timing of their output. Our
findings raise the possibility that sustaining cerebellar glutamate uptake may provide a therapeutic approach to
prevent this disruption and the glutamate excitotoxicity-induced PN death that signals the end point of the disease.
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The timing of excitatory synaptic responses at mamma-
lian glutamatergic synapses relies upon the rapid recruit-
ment of postsynaptic glutamate receptors and the rate of
clearance of glutamate from the synaptic cleft. Glutam-
ate clearance relies upon glutamate transporter carrier
proteins (excitatory amino acid transporters, EAATs) lo-
cated in close proximity to the synapse [1] that couple
glutamate movement with the Na+ electrochemical gra-
dient, H+ movement and a countertransported K+ ion
[2]. Furthermore, these transporters also behave like lig-
and gated ion channels, since glutamate activates their* Correspondence: ruth.empson@otago.ac.nz
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article, unless otherwise stated.inbuilt chloride conductance [3]. The functional import-
ance of the glutamate transporters in the cerebellum is
highlighted by the appearance of mutations in cerebellar-
enriched EAAT1 in human episodic ataxia type 6 [4-6],
the down-regulation of EAATs in animal models of the
human spinocerebellar ataxias SCA1, 5 and 7 [7-10]
and the mildly ataxic phenotype of mice lacking EAAT1
[11]. Interestingly, in episodic ataxia type 6, a mutation in
EAAT1 enhances this transporter’s anion conductance [4]
suggesting a potential role for these anion channels in
disease.
The main output neurons of the cerebellar cortex, the
Purkinje neurons (PN), are highly enriched for EAAT4
[12] present exclusively within the PN somatodendritic
compartment [12] and perisynaptic regions [13]. ThisCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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fibre (CF) and parallel fibre (PF) synapse responses [14].
Furthermore, since EAAT4 also exhibits the largest glu-
tamate activated chloride (anion) conductance it also has
the potential to directly modify the excitability of the PN
dendrite [15]. EAAT4 expression is heterogeneous across
the cerebellar cortex and enhanced levels coincide with
the expression of zebrin II-positive stripes [13] and ele-
vated glutamate release from CF terminals [16]. Under
certain conditions the elevated EAAT4 in zebrin II-
positive zones may exert a neuroprotective influence
against PN glutamate excitotoxicity [17]. More widely,
EAAT4 influences extrasynaptic transmission from PFs
to adjacent Bergmann glia [18] and controls metabotro-
pic glutamate type 1 receptor-mediated (mGluR1) syn-
aptic events at PF and CF synapses to influence plasticity
[19-21]. Without EAAT4, glutamate released by CF acti-
vation can even escape far enough to recruit basket cells
and drive intersynaptic GABAergic transmission [22].
EAAT3 (EAAC1) is less abundant in the cerebellum, but
like EAAT4, it locates to the somatodendritic compart-
ment of the PN [12]. Interestingly EAAT3 (also known
as EAAC1) is negatively modulated by its interacting
protein, glutamate transporter-associated protein 3-18
(GTRAP3-18) [23] and is known to transport cysteine
into cells to produce neuroprotective glutathione [24,25].
The cerebellar cortex also richly expresses the astro-
cytic forms of the glutamate transporters, particularly
EAAT1 (GLAST) and EAAT2 (GLT-1). Of the two,
EAAT1 is most enriched in the Bergmann glial cells [26]
and like EAAT4 also resides in close proximity to the
PN somatodendritic compartment [1]. Uptake of glu-
tamate by EAAT1 limits cross talk across cerebellar
synapses; it controls the amplitude and time course of
both CF-and PF-evoked AMPA receptor-mediated syn-
aptic transmission [27] by preventing glutamate escape.
EAAT1 mediated glutamate uptake also maintains the
one to one innervation of the PN by the CF [28] and the
independent operation of PF synapses [29]. Furthermore,
during CF activation EAAT1 controls the spread of glu-
tamate to nearby post-synaptic NMDA receptors on the
PN spine [30] and also to presynaptic NMDA receptors
on GABAergic terminals thereby also influencing local
synaptic inhibition [31].
Here we show how the non-transportable blocker of
EAATs 1-5, TBOA, (DL-threo-beta-benzyloxyaspartate,
hereafter referred to as TBOA) adversely influences the
behaviour of the PN and the PF-PN synapse, and discuss
how these mechanisms might influence cerebellar syn-
apse behaviour in the early stages of cerebellar ataxias.
We used brief bursts of high frequency physiologically
relevant PF activity to activate the PN (200 Hz EPSC),
and show how TBOA enhanced the amplitude and dur-
ation of the PN EPSC in an mGluR1 dependent andindependent manner. This enhanced depolarisation pro-
longed burst firing of the PN in response to PF input,
even when mGluR1 mediated excitation was blocked.
The excess glutamate made available by TBOA also re-
cruited abnormal PF presynaptic mGluR4 signalling that
modified the behaviour of the synapse. We predict that
these mechanisms have the potential to contribute to
mistimed cerebellar output during the onset and pro-
gression of some human cerebellar ataxias. Our findings
also highlight the importance of developing ways to sus-
tain cerebellar glutamate uptake as a useful early therapy
to prevent the progression of cerebellar ataxia.
Results
Inhibition of glutamate transport enhanced high frequency
stimulus-evoked parallel fibre EPSCs and revealed a
slow EPSC with mGluR1 dependent and independent
components
A burst of ten, high frequency (200 Hz) stimulations to
the PFs aimed to mimic the in vivo behaviour of PFs
[32] and evoked a large amplitude long-lasting EPSC in
cerebellar PNs, Figure 1 and Figure 2A, hereafter called
the high-frequency PF EPSC. To inhibit glutamate trans-
port we used 50 μM TBOA. This concentration of
TBOA significantly and reversibly enhanced both the
peak amplitude and the duration of the high-frequency
PF EPSC, Figure 2B. These changes occurred in the ab-
sence of any changes in the series resistance, input re-
sistance or holding current of the PN (see Methods
below). TBOA application also revealed a larger ampli-
tude slow component to the high-frequency PF EPSC
that was reduced by the broad spectrum mGluR1 antag-
onist, MCPG (0.2 mM), leaving a smaller amplitude,
slow EPSC remaining, Figure 2B. In the presence of the
AMPA and Kainate receptor (KA-R) antagonist CNQX
(6-cyano-7-nitroquinoxaline-2,3-dione) and TBOA and
MCPG (see also Table 1 for explanation),the fast peak
amplitude of the high-frequency PF EPSC reduced from
980 ± 167 pA in control to 112 ± 36 pA, n = 4, P < 0.001,
t-test, whilst the slower component EPSC reduced from
65 ± 16 pA to 2 ± 1.2 pA (see Figure 2A). This result in-
dicated that the majority of the TBOA-enhanced high-
frequency PF EPSC resulted from AMPA-R (α-Amino-3-
hydroxy-5-methyl-4-iso xazolepropionic acid receptors)
and KA-R activation. The NMDA (glutamate) receptor
antagonist APV (n = 6) did not influence the amplitude
or duration of the high-frequency PF EPSC in the pres-
ence of TBOA (mean values of the EPSC changed from
771 ± 66 pA for control to 1087 ± 88.3 pA in TBOA, P <
0.05, one way ANOVA, but remained unchanged at
1128 ± 124 pA in the presence of TBOA and APV, not
significant in one way ANOVA multiple comparison).
We also observed reversibility of the effects of 50 μM




























Figure 1 Location of all the major transporters and receptors at a PF-PN synapse. (A)(i) A biocytin filled Purkinje neuron post-hoc stained
with streptavidin Alexa 488. (ii) A representative image of a Parallel fibre Purkinje neurons synapse showing the approximate locations of the
major transporters and receptors targeted in this study. Parallel fibre synapses are located on the outer dendrites of Purkinje neurons, highlighted
by the white box in (Ai). (B) An example trace showing our stimulation and recording protocol. We used a 5 mV step to calculate series and input
resistance, followed by application of a pair of closely spaced stimuli to the parallel fibres and a high frequency burst stimulation (10 stimuli at
200 Hz), a protocol we repeated every 30 seconds.
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EPSC changed from 487 ± 64 pA to 674 ± 67 pA in
TBOA and back to 503 ± 65 pA (F2,11 = 14.7, P < 0.05,
one way ANOVA) and 291 ± 47 ms to 615 ± 118 ms and
back to 379 ± 55 ms respectively (F2,11 = 4.4, P < 0.05,
one way ANOVA). The time constant of the recovery of
the 2nd EPSC was also reversible, mean values changed
from 19.3 ± 1.7 ms to 30 ± 3.2 and back to 22.9 ± 2.5 ms
(F2,11 = 4.6, P < 0.05, one way ANOVA).
Subtraction of the high frequency PF EPSC signal from
the same signal in the presence of TBOA allows calcula-
tion of a difference current, seen in Figure 2A. This pro-
vides a quantitative index of the influence of glutamate
transporter activity on the EPSC, so that without a func-
tioning transporter we observe a greater current consist-
ent with greater availability of glutamate at the synapse.
The difference current also readily distinguishes the two
distinct phases of the TBOA-enhanced high-frequencyPF EPSC as additional AMPA-R, KA-R and mGluR1
receptors are recruited as a consequence of the greater
availability of glutamate. The initial phase, that influences
the peak of the EPSC, peaks at around 150 ms post stimu-
lation, while the slower phase peaks approximately
400 ms later. MCPG reduced the slow phase leaving a
small but measurable slow current, Figure 2C, but did not
significantly influence the early phase suggesting that this
is mediated exclusively by AMPA and KA-Rs, and as
shown in Figure 2A, further addition of AMPA-KA recep-
tor antagonist, CNQX, blocked all current.
Our findings confirm that a high frequency burst of
PF activity is sufficient to activate glutamate uptake by
TBOA sensitive glutamate transporters, consistent with
a large body of previous literature. The difference current
implies that under our experimental conditions, uptake
peaks approximately 100 ms after stimulation and con-









































































































































































Figure 2 Inhibition of glutamate transporters enhances PN responses to a short high frequency burst of parallel fibre activity. (Ai) A
burst of high frequency stimuli to the PFs evoked a large inward current in PNs (high-frequency PF EPSC). 50µM TBOA enhanced both the peak
amplitude and the duration of this current, further addition of 0.2 mM MCPG, a type 1 mGluR antagonist significantly reduced the slow
component of the high frequency EPSC leaving the peak current unchanged; CNQX, an AMPA-KA receptor antagonist abolished all current.
Difference currents (Aii) where the inward currents before and after TBOA, and TBOA and MCPG, are subtracted. Note that in the presence of
both TBOA and MCPG a small, slow current (note dashed line) remained, and this current was sensitive to the AMPA receptor antagonist CNQX
(Ai). All changes occurred in the absence of any significant changes in input or series resistance of the neuron, scale bar is 100 pA and 10 ms
(Aiii). B shows the individual and mean values of the changes in EPSC peak amplitude, duration and amplitude of the slow component of the
high-frequency PF EPSC, bars are mean values and error bars are SEM, filled circles show values from individual neurons and connecting grey lines show
how the responses changed in individual neurons; control, TBOA, and TBOA and MCPG. (Repeated measures oneway ANOVA, where * and ** represent
P < 0.05, P < 0.01 respectively, ns denotes not significant.) C shows the mean difference currents for the same cells as in B. The amplitude and time to
peak of the TBOA induced difference currents were unchanged by MCPG (P = 0.53 and 0.28 respectively) but the duration of the current significantly
shortened, statistical comparisons used paired T-test, * represents P < 0.05.
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Table 1 Table of major transporters and receptors
involved in this study
Receptor/Transporter Location Antagonist
EAAT1 Bergmann Glia TBOA
EAAT2 Bergmann Glia TBOA
EAAT3 Purkinje neuron (PN) TBOA
EAAT4 Perisynaptic on PN TBOA
AMPA/Kainate PN, postsynaptic density (PSD) CNQX
mGluR1 PN, edge of PSD (S)-MCPG
mGluR4 Parallel fiber presynapse MPPG
A list of major transporters and receptors used in this study along with their
associated antagonists and locations. DL-TBOA = DL-threo-β-Benzyloxyaspartic
acid, CNQX = 6-cyano-7-nitroquinoxaline-2,3-dione,
(S)-MCPG = (S)-α-Methyl-4-carboxyphenylglycine,
MPPG = (RS)-α-Methyl-4-phosphonophenylglycine.
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activation encourages a significant and long lasting de-
polarisation of the PN via the recruitment of AMPA, KA
and mGluR1 receptors.
Inhibition of glutamate transport enhanced Purkinje
neuron firing in response to high frequency PF input that
was refractory to the mGluR1 antagonist MCPG
In order to determine the consequence of reduced glu-
tamate transport for PN excitability we next assessed
how TBOA influenced spontaneous and burst evoked
action potential firing behaviour. Since the difference
currents (Figure 2A) indicate that the largest influence
of reduced transporter activity occurs approximately
100 ms after the last burst and that the slower compo-
nent peaks around 400 ms later, we analysed action po-
tential firing over these times and compared them with
pre stimulation firing.
As shown in Figure 3 TBOA significantly increased
the firing frequency at both 0-100 ms and 100-500 ms
after the stimulation, compared with basal, pre stimula-
tion firing frequency (Row factor in two way ANOVA
F2,24 = 96.8, P < 0.0001). Surprisingly, removal of mGluR1
mediated receptor activation (by MCPG) did not influ-
ence the post stimulation firing frequency (not signifi-
cant in two way ANOVA multiple comparisons). TBOA
also did not significantly influence the firing properties
of the PN measured in the 500 ms before the PF burst,
consistent with the lack of any significant change in
holding current of individual PNs by 50 μM TBOA (see
Methods).
Inhibition of glutamate transport reduced paired pulse
facilitation at the PF synapse via an mGluR4-mediated
mechanism
Although reduced glutamate uptake clearly amplified PN
excitability per se (Figure 2A) the excess glutamateunder these conditions could also influence PF-PN syn-
apse behaviour through presynaptic mechanisms. To test
this we used the fact that the low release probability PF
synapse exhibits the phenomenon of paired pulse facili-
tation (PPF). In this phenomenon, elevated residual pre-
synaptic calcium encourages greater glutamate release in
response to the second of a pair of closely spaced stimu-
lations. Changes in presynaptic properties that reduce
calcium influx are reliably predicted to reduce glutamate
release and to enhance the facilitation of the second
EPSC.
As seen in Figure 4, TBOA increased PPF at the PF
synapse. This result implies that excess glutamate avail-
ability reduced the probability of glutamate release at
this synapse. Importantly, in 7/11 cells we observed this
TBOA-enhanced PPF in the absence of any change in
the amplitude of the first EPSC, as seen in Figure 4A. In
the remaining 4/11 cells TBOA enhanced the 1st EPSC
and PPF, shown in Figure 4A, but we excluded these
cells since interpretation becomes more complex under
these circumstances. Note also that TBOA prolonged
the recovery of the second of the pair of EPSCs, see
Figure 4A, consistent with a slowed recovery of post-
synaptic glutamate clearance.
In order to search for the mechanism underlying the
TBOA-enhancement of PPF we omitted the high fre-
quency stimulation that we routinely applied within our
protocol (shown in Figure 1). Previous studies indicate
that cannabinoid plasticity at this synapse only occurs in
the presence of the high frequency bursts that mimic
in vivo PF behaviour [33]. Under these conditions a brief
burst of PF activity can cause mGluR1 activation and a
localised increase in Ca2+ concentration. This subse-
quently leads to an endocannabinoid mediated suppres-
sion of glutamate release from the PF via the CB1
receptor [34,35]. Similarly, when we omitted the high
frequency stimulation TBOA failed to influence PPF
(P = 0.16, n = 4, paired t-test). This strongly supported
the idea that an activity-dependent plasticity mechan-
ism contributed to the TBOA-induced enhancement of
the PPF. However, we ruled out an mGluR1-mediated
postsynaptic generation of a retrograde signal (such as
from cannabinoid release from the PN, [33]) since TBOA
continued to enhance PPF in the presence of 0.2 mM
MCPG, the type 1 metabotropic glutamate receptor
antagonist. Mean PPF was unchanged from 1.72 ± 0.07
to 1.73 ± 0.06, n = 12, not significant in multiple com-
parisons in a one-way ANOVA. Similarly, we excluded
an action from presynaptic NMDA receptors at PFs
[36] since the enhanced PPF persisted in the presence
of TBOA+APV (an NMDA receptor antagonist). Mean
values remained unchanged from 1.63 ± 0.04 to 1.64 ±




























































Figure 3 Inhibition of glutamate transporters enhances immediate and prolonged burst firing of PNs in response to a short high
frequency burst of parallel fibre activity. A, example cell-attached recording from a PN reveals how action potential firing changes during the
application of 50 μM TBOA and 50 μM TBOA in the presence of the mGluR antagonist 0.2 mM MCPG. Horizontal bar represents 200 Hz high
frequency stimulation to PFs. B, shows a raster plot for the cell shown in A, each sweep (horizontal dots represent each action potential in the
sweep) occurred at an interval of 30 seconds during the application of TBOA and TBOA and MCPG (left, vertical bars). Note the enhanced firing
after the burst in the presence of TBOA and the inability of MCPG to reduce this. Arrows represent the raster plot for the traces shown above.
C, bars show mean values (error bars are sem) of action potential firing frequency obtained from a 500 ms epoch just before stimulation, compared
with action potential firing frequency at the peak of the TBOA-induced 200 Hz EPSC (during the 100 ms after the end of the stimulation) and
later during the 400 ms after the stimulation when the slower, mGluR1 and EAAT4 dependent phase of the 200 Hz EPSC is active.
**** represents P < 0.0001, two way ANOVA, ns is not significant.

















































































































Figure 4 Inhibition of glutamate transporters enhances paired pulse facilitation at the PF-PN synapse and prolongs the decay of the
excitatory post synaptic current, EPSC. A, shows an example recording from a PN showing EPSCs evoked with a pair of closely timed single
stimulations to the PFs (downward arrows). Note the enhancement of the amplitude of the second EPSC upon application of 50 μM TBOA and
the concomitant increase in duration of the second EPSC, in the absence of any change in the amplitude of the first EPSC (in 7/11 cells shown in
A(i) where bars are mean ± SEM, ns is not significant in Student’s paired t-test). Dashed lines in A represent single exponential fits to estimate the
time constant of recovery of the second EPSC; mean values (error bars are SEM) shown in A(ii) ** represents P < 0.01 Student’s paired t-test. Inset
traces indicate no change in series resistance or input resistance by TBOA, see text, scale bar is 100 pA and 10 ms. B shows the change in mean
absolute values of PPF in Control and after 50 μM TBOA, bars are mean ± SEM, ** represents P < 0.01 Student’s paired t-test. Left panel shows PPF
change normalised to control for the 7/11 cells, bold colour, with remaining cells where the first EPSC increased, and PPF also increased, after
TBOA, shown in a transparent shade.
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tamate receptor known to be expressed presynaptically
at PFs [37] and known to depress their glutamate release
probability [38]. As seen in Figure 5A, 25 μM MPPG, an
antagonist of mGluR4 at PFs [39] abolished the TBOA-
enhanced PPF. MPPG did not influence the TBOA-
induced slower recovery of the second of the pair of
EPSCs nor did it prevent the enhanced amplitude of the
200 Hz evoked large EPSC (both P > 0.05 in multiple
comparisons from one way ANOVAs), see also Figure 5B.
This strongly supports the action of excess glutamate at
PF presynaptic mGluR4 receptors. MPPG also did not it-
self influence PPF, see Figure 5A, or the amplitude of
the first EPSC (mean values were unchanged from con-
trol 204 ± 26 pA to 217 ± 32 in MPPG and 239 ± 39 pA
in TBOA and MPPG, not significant in a one way
ANOVA). Although KA-R also contribute to enhanced
facilitation following high frequency PF stimulation [40]we did not observe any remaining PPF enhancement in
the presence of TBOA and MPPG suggesting that pre-
synaptic KA-R were unlikely to be recruited under our
conditions.
Discussion
Our findings illustrate that even a short period of re-
duced glutamate uptake adversely amplified synaptic re-
sponses at the PF-PN synapse to an extent that was
sufficient to prolong PN firing output. Furthermore, re-
duced glutamate uptake also changed the timing and be-
haviour of the PF-PN synapse by the action of excess
glutamate at presynaptic mGluR4 receptors.
The amplification of the PF-EPSC by TBOA is consist-
ent with previous literature showing the importance of
glutamate uptake at this and the climbing fibre (CF)-PN
synapse [14-18]. The difference currents in Figure 2





































































Figure 5 The mGluR4 (type III) receptor antagonist MPPG specifically prevented the change in paired pulse facilitation (PPF) upon
inhibition of glutamate uptake. A shows that application of 50 μM TBOA in the presence of the mGluR4 antagonist MPPG no longer changed
the PPF and that PPF was also not significantly changed by 25 μM MPPG alone. The graph shows the individual and mean values of the changes
in PPF, bars are mean values and error bars are SEM, filled circles show values from individual neurons and connecting grey lines show response
changes in individual neurons. The statistical comparison used a repeated measures oneway ANOVA where ns denotes not significant, F2,23 = 1.1,
P = 0.35. Importantly the first EPSC was also unchanged (data not shown) in these experiments, F2,23 = 4.4, P = 0.08. TBOA still increased the time
course of the recovery of the second of the pair of EPSCs, consistent with its postsynaptic action independent of the presence of MPPG, mean
values changed from 14.7 ± 1.6 ms in control cells, to 14.2 ± 1.5 ms in MPPG alone treated cells to 21.7 ± 3.4 ms in MPPG and TBOA treated cells
(F2,23 = 11.8, P < 0.05 repeated measures one way ANOVA). B shows for the same example cell as in A that the amplitude of the 200 Hz EPSC also
increased in the presence of TBOA and MPPG, the graph is as for A above with a repeated measures oneway ANOVA where F2,14 = 8.7, P < 0.05
and multiple comparisons where * represents P < 0.05 and ns denotes not significant.
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nent likely represents excess glutamate acting at AMPA/
KA receptors since it was abolished by CNQX. Likewise,
the slow component was abolished by the type 1 metab-
otropic glutamate receptor antagonist MCPG, as shown
by others at both PF and CF synapses [14,19,20], how-
ever a significant slow inward current remained. The
fact that the AMPA-R antagonist CNQX abolished this
slow MCPG-insensitive inward current in the PN indi-
cates that it is a consequence of glutamate acting at glu-
tamate receptors (including low affinity KA-R) [27].
Since previous work indicates that it is also absent in
EAAT4 knockout mice [41] we propose that the slow
current is driven by the opening of glutamate receptors
(probably K-AR) as a consequence of excess available
glutamate following EAAT4 inhibition by TBOA. The
small, slow nature of the current is consistent with
EAAT4 actions since EAAT4 is a high affinity glutamate
transporter normally responsible for clearing the last
remaining glutamate after PF stimulation; hence this
slow current is most apparent in the presence of TBOA.In accordance with this previous literature we also ob-
served a significant overlap between the mGluR insensi-
tive, CNQX sensitive slow current (EAAT4 action) and
the mGluR1-sensitive, CNQX insensitive current
(mGluR1 action), Figure 2A. The overlap of timing of
these two components is consistent with the idea that
mGluR1 responses are limited in PNs within zebrin II-
positive zones [20] where EAAT4 expression is highest
[13] but are facilitated in PNs from EAAT4 knockout
mice [18].
EAAT4 is known to have a large anion conductance
compared to other EAATs [42], these anion currents,
under resting conditions may inhibit cell excitability. It
has also been speculated that EAAT4s hyperpolarising
action could counteract the depolarising action of other
EAATs, namely EAAT3. However, another report by
Melzer [43] showed that during large depolarisations the
EAAT4 transporter may become cation permeable and
cause an excitatory inward current. A further consider-
ation is that whilst EAAT4 currents may directly influ-
ence the local membrane potential in the PN dendrites
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inward current recorded from the PN soma seen here,
especially considering its susceptibility to CNQX.
Inhibition of glutamate uptake prolongs Purkinje neuron
firing output in response to PF input
We expected the sizeable fast and slow excitatory inward
currents evoked by high-frequency PF stimulation in the
presence of TBOA to alter the excitability of the PN. As
seen in Figure 3, TBOA dramatically influenced PN fir-
ing behaviour, particularly in the 100 ms period immedi-
ately after the burst stimulation when TBOA-enhanced
depolarisation was at its maximum (see Figure 2). Al-
though this short lasting burst firing behaviour was rem-
iniscent of CF activation the responses remained graded
and did not exhibit the all-or-none behaviour character-
istic of CF activation. The enhanced PN firing also per-
sisted during the time when the mGluR1 and EAAT4
dependent current were active (Figure 3). It was there-
fore surprising that blockade of mGluR1 did little to in-
fluence PN firing (Figure 3C). This suggests that the
small remaining slow CNQX sensitive current (pre-
sumed to be driven by EAAT4) is sufficient to drive the
membrane potential above the PN action potential
threshold. It is possible, since EAAT4 is uniquely
expressed in the PN dendrites [12,13] that this gluta-
matergic current exerts a far more powerful contribution
in the dendrite and only appears small and slow from
our recordings at the soma. Alternatively, or in addition,
since TBOA blocks the EAAT4 chloride conductance
this may directly enhance PN dendrite excitability to
sustain bursting behaviour.
Inhibition of glutamate uptake recruits PF presynaptic
metabotropic glutamate receptors (mGluR4) to reduce
glutamate release from PFs
Blockade of glutamate transporters also enhanced the
phenomenon of paired pulse facilitation, a form of short
term plasticity displayed by the PF synapse [44]. At this
synapse, enhanced PPF indicates reduced presynaptic
calcium and reduced glutamate release. We propose that
TBOA reduced glutamate release may indicate an in-
built plasticity mechanism to conserve overall synaptic
weight at the PFs under conditions of excess glutamate
[45,46]. Indeed, depression of transporter current re-
sidual CF EPSCs in double EAAT4 EAAT1 knockout
mice also suggests that excess glutamate reduces glu-
tamate release at CF synapses [41]. Critically, the re-
duced glutamate release at PFs required inhibition of
glutamate uptake AND high frequency bursts, indicative of
an activity dependent mechanism. Of the possible candi-
dates, neither NMDA nor mGluR1-mediated mechanisms
influenced the TBOA-induced change in PPF, rather it was
prevented by the mGluR4 antagonist MPPG, a findingconsistent with the unique presence of mGluR4 at PFs
[37,38]. These receptors reduce glutamate release from PFs
by reducing calcium influx [47] and by directly interacting
with the release machinery [48,49]. MPPG alone did not
change the behaviour of the PF-PN synapse suggesting that
the combination of excess glutamate (by TBOA) and high-
frequency stimulation together enabled sufficient glutam-
ate to reach the PF presynaptic mGluR4 receptors. Indeed,
a previous study showed that several seconds of PF stimu-
lation is needed to activate mGluR4 [50]. The important
consequence of mGluR4 recruitment in the face of excess
glutamate is to usefully weaken, or balance, the PF-PN syn-
apse. It is tempting to speculate that a similar mechanism
contributes to long term depression (LTD) at this synapse,
a phenomenon traditionally linked to motor learning.
Interestingly, an orally active mGluR4 positive allosteric
modulator influences motor behaviour [51].
Conclusions
Relevance for cerebellar ataxia
Our findings predict that loss of glutamate transporter
activity leads to excessive and mis-timed PN output and
altered PF plasticity that could lead to defective cerebel-
lar output. Such changes are likely to take place during
pre-symptomatic or early stages of a variety of human
ataxias and mouse models of human ataxias [2-7]. Our
results imply that chronic loss of transporter activity
during progression of ataxia will be accompanied by hy-
perexcitability, oxidative stress, excitotoxicity and death
of PNs. Since PN death is the end point of the disease
novel therapeutic approaches to sustain EAAT trans-
porter activity in the early phases of the disease merit
serious attention. Possible approaches include reduced
expression of GTRAP3-18, a protein that normally re-
duces EAAT3 activity [23], activation of innate compen-
satory mechanisms to elevate glutamate uptake [52] or
selective stimulation of JAK kinases known to elevate




We used male C57 B6 mice aged 22-30 days. All animal
husbandry and ethical procedures minimized animal suf-
fering and followed internationally recognized standards
as part of University of Otago approved guidelines in ac-
cordance with New Zealand Animal Welfare Act (1999).
Electrophysiology
300 μm thick saggital slices from the cerebellar vermis
were prepared from mice following rapid anaesthesia
with carbon dioxide. Slices were maintained at 24°C
(TC324B, Harvard Apparatus, USA) in a flow (3 ml/
min) of artificial cerebrospinal fluid (aCSF), equilibrated
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http://www.cerebellumandataxias.com/content/1/1/3with 95% O2 and 5% CO2, containing (in mM) NaCl
126, KCl 2.5, NaH2PO4 1.2, MgCl2 1.3, CaCl2 2.4,
NaHCO3 26, glucose 10. Whole cell recordings from PN
soma under visual control used glass electrodes (3-5
MΩ) containing (in mM) KCl 4.5, KOH 20, MgCl2 3.48,
NaCl 4, K gluconate 120, Hepes 10, sucrose 8, Na2ATP
4, Na3GTP 0.4, 10 mM EGTA pH 7.3 and osmolarity
305 mOsm/l. Voltage clamp (Axopatch 200B, Molecular
Devices, USA) maintained cells at -70 mV holding
current for at least 5 minutes prior to electrophysio-
logical protocols (PClamp, Molecular Devices, USA).
Mean uncompensated series resistance was 18 ± 1.1 MΩ
in control and 17.5 ± 1.2 MΩ in 50 μM TBOA, P > 0.05,
n = 12, paired t-test; TBOA also did not influence PN in-
put resistance or holding current, mean values were un-
changed from 85.2 ± 3 to 87.6 ± 3.7 MΩ and from
-154.7 ± 21.9 pA to -188.8 ± 29.7 pA, both P > 0.05, n =
12, paired t-test. PF stimulation (10 μs, 2-20 V, constant
voltage stimulator, Digitimer, UK). Capacitance and in-
put resistance were estimated from the current change
during a 5 mV step. We used a pair of stimuli for PPF
measurements separated by an inter-stimulus interval of
50 ms, and also a burst stimulus delivered 550 ms post
PPF stimulation, consisting of 10 stimuli at 200 Hz (5 ms
interval) (see Figure 1). Both types of stimulus were deliv-
ered at 0.011 Hz (every 30 seconds) using a glass aCSF-
filled monopolar stimulation electrode (200-600 kΩ)
placed in the outer two thirds of the molecular layer
approximately 120-150 μm from the recorded cell and
the burst stimulus followed the PPF stimulation Figure 1).
Loose patch recordings (Axopatch 200B) from the soma of
PNs used glass electrodes with a resistance of approximately
6 MΩ employing the same internal solution as above.
Solutions and pharmacological treatments
EPSCs were evoked in the presence of 50 μM picrotoxin
(Sigma-Aldrich, UK) and prevented by 20 μM CNQX,
(1,2,3,4-Tetrahydro-6-nitro-2,3-dioxo-benzo[f]quinoxa-
line-7-sulfonamide (Tocris Cookson). Electrophysiology
protocols were repeated after 10-15 minutes bath ap-
plication of TBOA (50 μM, (Sigma-Aldrich) a broad
spectrum inhibitor of glutamate transport (10-50 μM,
Tocris Cookson). Pharmacological tools included 0.2 mM
(S-)MCPG, (S)-α-Methyl-4-carboxyphenylglycine and 25 μM
MPPG, (RS)-α-Methyl-4-phosphonophenylglycine all stored
as a 1000× stock solution in DMSO or water. (See Table 1
for list of antagonists used).
Control applications of vehicle instead of TBOA over the
same time period revealed no significant changes in any of
our measured parameters (P > 0.05, n = 4, paired t-tests).
Analysis and statistics
Offline analysis of all electrophysiological data used
PClamp 9 (Molecular Devices, USA). Slow inward currentamplitudes were measured at 500 ms after the onset of
the high frequency stimulation, time constants of recovery
of EPSCs used a single exponential fit. Statistical analysis
was performed in Prism 6.0 (GraphPad) and Student’s
t-test and one and two way ANOVAs as appropriate.
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